ATE471156T1 - Antigene zusammensetzungen zur immunisierung nichtmenschlicher säuger gegen streptococcus equi - Google Patents

Antigene zusammensetzungen zur immunisierung nichtmenschlicher säuger gegen streptococcus equi

Info

Publication number
ATE471156T1
ATE471156T1 AT03751693T AT03751693T ATE471156T1 AT E471156 T1 ATE471156 T1 AT E471156T1 AT 03751693 T AT03751693 T AT 03751693T AT 03751693 T AT03751693 T AT 03751693T AT E471156 T1 ATE471156 T1 AT E471156T1
Authority
AT
Austria
Prior art keywords
equi
human mammals
subsp
mammals against
streptococcus equi
Prior art date
Application number
AT03751693T
Other languages
English (en)
Inventor
Bengt Guss
Jan-Ingmar Flock
Karin Jacobsson
Kenneth Janzon
Lars Frykberg
Margareta Flock
Rune Bergman
Original Assignee
Bengt Guss
Jan-Ingmar Flock
Karin Jacobsson
Kenneth Janzon
Lars Frykberg
Margareta Flock
Rune Bergman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bengt Guss, Jan-Ingmar Flock, Karin Jacobsson, Kenneth Janzon, Lars Frykberg, Margareta Flock, Rune Bergman filed Critical Bengt Guss
Application granted granted Critical
Publication of ATE471156T1 publication Critical patent/ATE471156T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Gram-positive bacteria
    • C07K16/1275—Streptococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55544—Bacterial toxins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AT03751693T 2002-10-11 2003-10-10 Antigene zusammensetzungen zur immunisierung nichtmenschlicher säuger gegen streptococcus equi ATE471156T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41766002P 2002-10-11 2002-10-11
PCT/SE2003/001587 WO2004032957A1 (en) 2002-10-11 2003-10-10 Immunization of non-human mammals against streptococcus equi

Publications (1)

Publication Number Publication Date
ATE471156T1 true ATE471156T1 (de) 2010-07-15

Family

ID=32094057

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03751693T ATE471156T1 (de) 2002-10-11 2003-10-10 Antigene zusammensetzungen zur immunisierung nichtmenschlicher säuger gegen streptococcus equi

Country Status (9)

Country Link
US (1) US8404245B2 (de)
EP (1) EP1560594B1 (de)
AT (1) ATE471156T1 (de)
AU (1) AU2003269765B2 (de)
CA (1) CA2501621C (de)
DE (1) DE60333027D1 (de)
DK (1) DK1560594T3 (de)
NZ (1) NZ539255A (de)
WO (1) WO2004032957A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9023366B2 (en) 2003-07-01 2015-05-05 The Royal Veterinary College Vaccine composition for vaccinating dogs against canine infectious respiratory disease (CIRD)
GB0315323D0 (en) 2003-07-01 2003-08-06 Royal Veterinary College Vaccine composition
WO2007115059A2 (en) 2006-03-29 2007-10-11 Merial Limited Vaccine against streptococci
US20110020403A1 (en) * 2007-12-13 2011-01-27 Bengt Guss immunizing composition
WO2011059385A1 (en) * 2009-11-13 2011-05-19 Bengt Guss Immunizing composition for reducing streptococcal infections
WO2011149419A1 (en) 2010-05-26 2011-12-01 Intervacc Ab Vaccine against streptococcal infections based on recombinant proteins
CN103958542A (zh) * 2011-09-23 2014-07-30 抗菌技术,生物技术研究与发展股份有限公司 经修饰的白蛋白结合结构域及其用于改善药代动力学的用途
CN114437235B (zh) * 2022-01-04 2024-02-09 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） 马链球菌马亚种8种蛋白的重组融合蛋白及其制备方法和应用
CN120173928B (zh) * 2025-05-22 2025-09-19 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） 马链球菌马亚种前噬菌体裂解酶及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR241545A1 (es) 1985-07-12 1992-08-31 Cornell Res Foundation Inc Un metodo para preparar una cepa de s. equi avirulenta a.t.c.c. 53186 para equinos.
US5583014A (en) 1990-07-03 1996-12-10 Bayer Corporation Preparation and use of enzyme-detergent extracted Streptococcus zoopidemicus vaccine
SE9003374D0 (sv) 1990-10-22 1990-10-22 Alfa Laval Agri Int A collagen binding protein as well as its preparation
SE9302855D0 (sv) 1993-09-06 1993-09-06 Martin Lindberg Method and means for producing plasmaproteinase inhibitor binding proteins
IES76925B2 (en) 1996-07-03 1997-11-19 Provost Subunit Vaccine for Streptococcus Equi
SE9804491D0 (sv) 1998-12-22 1998-12-22 Bengt Guss Novel fibronectin-binding protein

Also Published As

Publication number Publication date
NZ539255A (en) 2007-12-21
EP1560594B1 (de) 2010-06-16
US8404245B2 (en) 2013-03-26
HK1085646A1 (en) 2006-09-01
DK1560594T3 (da) 2010-10-04
AU2003269765A1 (en) 2004-05-04
AU2003269765B2 (en) 2009-08-06
WO2004032957A1 (en) 2004-04-22
US20060140980A1 (en) 2006-06-29
EP1560594A1 (de) 2005-08-10
CA2501621A1 (en) 2004-04-22
DE60333027D1 (de) 2010-07-29
CA2501621C (en) 2012-01-24

Similar Documents

Publication Publication Date Title
IS4518A (is) Nýtt lyfjaform fyrir bóluefni
DE602004028468D1 (de) Haltung von immunantworten gegen mhc-klasse-i-beschränkte epitope, für prophylaktische oder therapeutische zwecke
ATE513560T1 (de) Kombinationsimpfstoff gegen bakterielle meningitis, der über die schleimhaut appliziert wird
WO2005037190A3 (en) Multiplex vaccines
ATE501726T1 (de) Zusammensetzung mit immunogenen mikroteilchen
PT2364724E (pt) Composição de vacina compreendendo um adjuvante de saponina
CY1115842T1 (el) Συμπληρωμενο ομv εμβολιο κατα μηνιγγιtiδοκοκκου
ATE198051T1 (de) Pneumokokken-polysaccharid-rekombinante- pneumolysin-konjugate als impfstoffe für die immunisierung gegen pneumokokken-infektionen
BR0114786A (pt) Composição imunogênica, método de tratamento de um paciente que sofre de, ou que é suscetìvel a, um câncer, e, uso de uma combinação de uma saponina, um oligotìdeo imunoestimulador e um antìgeno de câncer, e, método para a manufatura de uma composição
WO1999041383A8 (en) Antigen library immunization
DK1147117T3 (da) Immunologiske adjuvansforbindelser
WO2003011223A3 (en) Immunomodulatory compounds and methods of use thereof
MA29406B1 (fr) Vaccin toxoide alpha de c. perfringens
WO2006126981A3 (en) Compositions and methods for mucosal vaccination
DK2054431T3 (da) Konformere af bakterielle adhæsiner
NO20063254L (no) Immunstimulerende sammensetning omfattende minst en toll-lignende reseptor 7 eller toll-lignende reseptor 8 agonist og en toll-lignende reseptor 4 agonist
AU2003206532A1 (en) Synthesis of lipopolysaccharide-protein conjugate vaccines via the lipid a region following removal of the glycosidic phosphate residue
ATE471156T1 (de) Antigene zusammensetzungen zur immunisierung nichtmenschlicher säuger gegen streptococcus equi
EA200700496A1 (ru) Инактивированная полиомиелитная вакцина, полученная из штамма сейбина вируса полиомиелита
WO2005028618A3 (en) Immunogenic compositions for streptococcus agalactiae
ATE364395T1 (de) Konjugat-impfstoffe zur vorbeugung der zahnkaries
AU2001284354A1 (en) Immunological adjuvant compounds, compositions, and methods of use thereof
WO2003083083A3 (en) Methods of using flt3-ligand in immunization protocols
ATE450272T1 (de) Rekombinantes adenylat-cyclase-toxin von bordetella induziert t-zell-antworten gegen tumorale antigene
ATE353226T1 (de) Adjuvanszusammensetzung enthaltend fha oder ein fha-fragment in freier form

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties